ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, EMILIN1, HOXA5, CCR2, HSPG2, DCN, HGS, CX3CR1, THBS1, TGFB2, PLK2, TIE1, CXCL10, TEK, PF4]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, GH1, KIT, CD28, PTPN6, TEK]
GO:0035684;helper T cell extravasation;9.0;0.8933024483968273;0.8428918493787028;9.474373572664863;63.467001142674015;9.777073627680469;0.002124183411652594;0.896240625180289;[CCL2]
GO:0036499;PERK-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.292166977892469;0.0026782155121157316;0.6960420709600095;[CCL2, EIF2S1, ATF3]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[CCL2, DLL1]
GO:0060129;thyroid-stimulating hormone-secreting cell differentiation;8.0;1.0;0.875;9.628524252492122;56.29999269909438;8.67846133901236;0.0018843100889348208;0.8188169164668168;[BMP2]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IFNA2, GHR, CCL5, FYN, IL6R, LYN, GH1, IL6, IFNG, KIT]
GO:0008343;adult feeding behavior;3.0;1.0;0.6981203125901445;9.628524252492122;24.575257889458463;7.474488534686424;8.225117652639858E-4;0.5803660038532718;[GHSR, NPY]
GO:0021954;central nervous system neuron development;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;34.232648149996464;6.343086423195323;0.0011457359261972313;0.6146267465268138;[ROBO2, GABRB1, UQCRQ, NPY]
GO:0022009;central nervous system vasculogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;8.390779266560578;7.282666309192915E-4;0.7193458537639684;[ENG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CDH5, C3AR1, CTSH, CYP1B1, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, PLCG1, JUP, PLK2, TNFSF12, LRG1, TEK]
GO:0060128;corticotropin hormone secreting cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;9.083926447120524;7.050676185779127E-4;0.714552420951524;[BMP2]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[LYN, PRL, GHR, GH1, STAT4, CCL2, CCR2]
GO:0001300;chronological cell aging;4.0;1.0;0.75;9.628524252492122;26.138269705024182;9.083926447120524;8.748243641116619E-4;0.714552420951524;[ENG]
GO:0001542;ovulation from ovarian follicle;4.0;1.0;0.75;9.628524252492122;27.16069640012757;7.697632086000634;9.090440654724862E-4;0.6436572628545723;[ADAMTS1, MMP19, SIRT1]
GO:0031638;zymogen activation;7.0;0.8259837884571596;0.7639112594857803;9.387362195675234;102.5832240862455;6.113511981550823;0.00343336819125881;0.663564652301091;[F11, CD5L, DHCR24, CTSH]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, BMP2, CD40LG, CSPG4, PKN1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, EGR1, TGFB2, TGFB1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, ALAD, MYOCD, ADSL, KCND2, AGTRAP, SIRT1, TGFBR3, IL1B, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, TEK]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, ENG, CTGF]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[CCL13, CXCL9, CCL23, CCL21, CCL20, DEFA1, CXCL13, CXCL16, CXCL10, CXCL11, CCL8, CCL7, CCL5, CCL4, CCL2, XCL1, CCL1, CCL19, CCL18, CCR2]
GO:0060804;positive regulation of Wnt signaling pathway by BMP signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;475.65903384128745;9.777073627680469;0.01591987979732979;0.9481203125901445;[BMP2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, PLCG1, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0071773;cellular response to BMP stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.280566066213989;0.003262744749111514;0.6443087532925187;[TMEM100, BMP2, SPINT1, SPINT2, GATA3, ADAMTS12, RUNX2]
GO:0048246;macrophage chemotaxis;8.0;1.0;0.875;9.628524252492122;95.91852822164125;7.212124270218933;0.0032103068185073717;0.7438283705770736;[CX3CR1, LGALS3, EDNRB, NUP85, CCL5, CCL2, AZU1]
GO:0048245;eosinophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;6.7325511899570465;0.004360933283440787;0.740543606130341;[LGALS3, CCL13, CCL23, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[DLL1, MEF2C, ENG]
GO:0010536;positive regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;2488.7782735422925;7.8311634786251565;0.08329716906043155;0.8329150168128974;[GH1, CCL5, IL6R]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, GPNMB, CD34, HAVCR2, GHSR, LILRB1, IRAK3, BPI, TLR4, GPR18]
GO:0071657;positive regulation of granulocyte colony-stimulating factor production;7.0;1.0;0.8509193652572005;9.628524252492122;82.44381255092301;8.67846133901236;0.0027593202114652195;0.7947362817240173;[CD34]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[TNF, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL17RB, IL1B, BTK, AGTR1, TLR10, TLR7, TLR6, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, PTGS2, PLA2G7, CNR1, CCL4, CCL18, CCL23, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[CHRM2, GABRB1, CHRM1, GRIK3, GRM5, CHRNB4, KCND2, NPY1R, SLC5A7, SLC1A3, SLC1A6, GJC1, SV2A, NPY, HRH4, KCNMB3, SLC17A6, GABRE, DRD4, EGR3, HTR1E, GABRA5, PCDHB15, PCDHB14, PCDHB10, P2RX1, PNOC, PCDHB16, PLP1, PMP22, PCDHB4, PCDHB8, GPR19]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, PID1, EDNRB, AKT1, PRKACB, PTGDR, MEF2C, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, COL1A1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BRCA2, CTSS, CTSH, TIMP3, CCR7, TIMP1, CTSB, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, CEACAM1, IL1B, KIT, MMP19, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, GNAI1, PAK1, CCL19, CCL21, SORT1, SORBS1, RAMP1, TNC, TNF, CTGF, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, ADCYAP1, ADAM9, FOXO1, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, CXCL12, NR4A3, NASP, ALPL, HMGB2, GHR, ALAD, HHEX, UQCRFS1, GLP2R, TGFBR3, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, TEK]
GO:0003222;ventricular trabecula myocardium morphogenesis;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;28.30750056401912;7.004484905440688;9.474265687811956E-4;0.7091290490632969;[TGFB2, ENG]
GO:0045019;negative regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.5757278387367;7.292166977892469;0.022108875131204346;0.747921758369865;[CAV1, CD34]
GO:0010828;positive regulation of glucose transmembrane transport;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;65.58818238534796;5.845247994956144;0.0021951774389057117;0.6498456195510879;[PAK1, AKT1, MEF2A, SORBS1, MAPK14, GH1, NR4A3]
GO:2000404;regulation of T cell migration;9.0;0.6954798709641801;0.743980560662379;9.168991923113682;54.41624510224751;6.250713103064308;0.0018212627521311273;0.7159023839588838;[ECM1, TNFSF14, CCL21, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR6, CCR2]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:2001214;positive regulation of vasculogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;246.74152534447236;7.474488534686424;0.008258216800323579;0.7331650565203278;[TMEM100, CEACAM1, CD34]
GO:0070278;extracellular matrix constituent secretion;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;23.0991473088411;8.67846133901236;7.731076725439974E-4;0.7669372290569613;[ENG, CTGF]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, P2RY13, TNC, TNF, SLC8A1, CDH1, RUVBL2, ADCYAP1, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GAB1, VAV1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, C5AR1, FPR1, TGFA, TNFRSF11A, IQGAP3, PDGFD, PDGFC, ELANE, DRD4, MAP2K6, TGFB1, FZD5, GH1, BMP2, NOX4, CSPG4, CD24, EZH2, LRRK2, GHR, MAP4K1, SYK, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, THBS1, PAK1, NTF3, CSK, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, CYP1B1, EPHB1, SOX4, MEF2C, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FABP7, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[GOLT1B, TNF, AKT1, TNFSF11, F2R, CARD11, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, FLNA, FYN, CCL19, CCL21, CARD9, CD4, LTBR]
GO:0006024;glycosaminoglycan biosynthetic process;6.0;0.7586651285174919;0.7024528768488905;9.158520623246385;237.49504005673018;5.16195311083921;0.007948745259039342;0.5871028347338303;[SDC2, NDST3, ST3GAL6, PDGFRB, HS3ST3B1, LUM, OMD, HSPG2, DCN, IL1B, OGN, SDC1, CSPG4]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, AXIN2, MAPK14, RUNX2, BMP2]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, MIF, AURKAIP1, GATA3, TP53BP2, SFN, BARD1, PLK2, CDC6, ZWINT, STAG2, EZH2, CDKN1A, PTPRK, BRCA2, DUSP1, GAS1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, SIPA1, GMNN, TNF, KNTC1, MEN1, MSH6, ADCYAP1, MSH2, BLM, CUL5, NACC2, NAE1, GAS2L1, MAP2K6, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, BCL6, CNOT3, JMY, TNFAIP3, HHEX, TOPBP1, MYOCD, SMC1A, IFNG, PPP1R15A, THBS1, RBBP8, CCL2, BUB1, E2F7, MAPK14, WEE1, RAD51]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, LYN, SYT2, BMP2, CXCL12, LIN28A, BCL6, TCF4, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:1900035;negative regulation of cellular response to heat;7.0;1.0;0.8509193652572005;9.628524252492122;86.21233357930694;9.777073627680469;0.002885449218836496;0.8509193652572005;[CD34]
GO:0003273;cell migration involved in endocardial cushion formation;6.0;1.0;0.8231203125901445;9.628524252492122;22.825287336738096;8.390779266560578;7.639418257356832E-4;0.7522251544931926;[ENG]
GO:1900038;negative regulation of cellular response to hypoxia;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;86.50001565176053;7.8311634786251565;0.002895077678904461;0.7514054297404357;[CD34]
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;12.0;0.7140352122741334;0.8051379187272112;9.260799472366804;1467.8987330058965;6.641579411751319;0.04912924957061573;0.7877709925721352;[RUNX2, BMP2]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0060389;pathway-restricted SMAD protein phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.212124270218933;0.006049650283656873;0.7438283705770736;[TGFBR3, TGFB2, BMP2, TGFB1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, CEBPE, ABLIM3, E2F5, E2F7, PRRX1, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0006029;proteoglycan metabolic process;6.0;0.7140352122741334;0.6801379187272112;9.057979394024509;96.66964063832829;5.825829909099042;0.0032354458751365986;0.6210535250702663;[COL11A1, ADAMTS12, NDST3, HS3ST3B1, SULF2, BMP2]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[GHSR, GHR, GH1]
GO:0006027;glycosaminoglycan catabolic process;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;234.16675596998346;5.618190544320798;0.00783735058591714;0.610434838299289;[SDC2, GNS, PKHD1, TGFB1, LUM, FUCA1, OMD, HSPG2, DCN, OGN, SDC1, CSPG4]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, PROS1, ITGB3, ITGA2B, F13A1, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, PCDH7, LHFPL2, PPBP, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[TGFB1, TSC2, TNF, PAX2, TMEM100, CCL5, IL1B, AKT1, CCL2, EPHA2]
GO:0001523;retinoid metabolic process;8.0;0.7671156992804218;0.7585578496402109;9.193206181234276;47.546147792504925;5.334422371190153;0.0015913267778602078;0.6478026081386739;[LRP1, SDC2, LRP2, TTR, CYP1B1, DGAT2, HSPG2, ALDH1A1, SDC1]
GO:0001766;membrane raft polarization;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;30.900032201834875;7.697632086000634;0.0010341962695718944;0.7167775754447168;[CD2, CMTM8, MAL, MAL2]
GO:0003308;negative regulation of Wnt signaling pathway involved in heart development;8.0;0.7763722522362496;0.7631861261181248;9.352270875863963;319.9618777477182;8.390779266560578;0.010708836101221256;0.8041048419030481;[BMP2]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, CACNA1F, CORO1A, CCR1, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, NPY, FYN, CCL19, CCL21, RAMP1]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, CYR61, FBL, AKT1, MEF2C, TPM4, RUNX2, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, RBMX, LGR4]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, SOX4, PCNA, GPNMB, NACC2, CCL2, SFN, E2F7, PLK2, CNOT3, EZH2]
GO:0071559;response to transforming growth factor beta;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;24.053434438352202;5.649939242635378;8.050468039660755E-4;0.5791791674783379;[CX3CR1, EPB41L5, PDGFD, FYN, MEN1, MEF2C, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1, ENG]
GO:1900041;negative regulation of interleukin-2 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.390779266560578;0.02523477878196853;0.8443458537639685;[CD34]
GO:0006032;chitin catabolic process;7.0;0.811012628672052;0.7564256795932265;9.474373572664863;407.1521334841612;7.8311634786251565;0.013627015494584295;0.7514054297404357;[CHIT1, CHI3L2, CHI3L1]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[LAMC1, MMP8, MMP9, CTSS, MMP12, MMP19, CTSG, TIMP1, ELANE]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[EGR3, COL1A1, NR4A1, CCL5, CCL2]
GO:1900168;positive regulation of glial cell-derived neurotrophic factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;670.4837428191056;9.083926447120524;0.022440487475962726;0.8797934328124444;[CD34]
GO:0097084;vascular smooth muscle cell development;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;32.84635378887841;7.697632086000634;0.001099337901514535;0.6838982747154925;[ENG]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, LGALS3, CXCL12, CCL2]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, ADCYAP1, KIT, MMP19]
GO:0030513;positive regulation of BMP signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.571365838652174;514.640204837359;6.311337724880743;0.017224544509792043;0.770882417347765;[CYR61, ENG]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[CCL2]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0010922;positive regulation of phosphatase activity;9.0;0.7586651285174919;0.775573189439035;9.267510906954792;265.2783726737478;6.311337724880743;0.008878628398354923;0.7190027299379095;[PDGFRB, PPP1R15A, MEF2C, PPP1R12A, FCRL3, BMP2, IFNG]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, BMP2]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, CSF3R, C5AR1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0031960;response to corticosteroid;6.0;0.7140352122741334;0.6801379187272112;9.05316010758856;61.63829009254609;4.689477292448085;0.0020629780985379075;0.5629403994089356;[CDKN1A, TNF, CTGF, ALAD, GHSR, ANXA1, DUSP1, ANXA3, ARG1, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, ENG, PCNA, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, COL1A1, IL6, ALPL, SDC1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, PROS1, SIRPG, CXCL13, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, CXCL10, CXCL11, IL6, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, OLR1, FFAR2, CCR7, CCR6, CCR5, CD34, CCR2, ANXA1, FCER1G, SYK, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, AKT1, PLCG1, GHSR, JUN, EGR3, ARG1, CAV2, TNFSF12, SIRT1, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0010760;negative regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;861.5414298964416;7.9853141584524145;0.02883501632168613;0.8236103492792612;[MMP28, STAP1, MIF]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, PLXND1, LRRK2, MEN1, MEF2C, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:1905065;positive regulation of vascular smooth muscle cell differentiation;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;295.7578040146463;7.9853141584524145;0.009898747535627478;0.7833693374183408;[MYOCD, KIT, ENG]
GO:0030195;negative regulation of blood coagulation;8.0;0.7763722522362496;0.7631861261181248;9.387362195675234;250.95291648915588;5.905872616772578;0.008399168271930173;0.6770266002729131;[PDGFRA, PROS1, F11, GP1BA, CEACAM1, CD9, CD34]
GO:0003130;BMP signaling pathway involved in heart induction;12.0;1.0;0.9481203125901445;9.628524252492122;313.8403138086527;9.083926447120524;0.010503952865230601;0.9126727335416687;[BMP2]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[PTGS2, FRZB, PRDM16, AKT1, TMEM64, MAPK14, BMP2, KLF5, SFRP2]
GO:0048711;positive regulation of astrocyte differentiation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;472.09912929902924;7.069023426578259;0.015800732996006494;0.7767511986393403;[BMP2, IL1B]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0030502;negative regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;172.15796001199809;6.943860283624253;0.005761971989496609;0.7060287030842711;[CCR1, ECM1]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD86, CD83, TFRC, CD80, SIRPG, PYCARD, GRAP2, MYB, AKT1, TNFSF11, IL6R, ICOSLG, PRKCQ, CARD11, CD274, BLM, HHLA2, GATA3, CD1D, CORO1A, DPP4, KLRK1, BTLA, NLRP3, NCKAP1L, ICOS, LYN, TGFB1, EGR3, TNFSF14, CAV1, IL6, VNN1, PTPRC, BCL6, CD28, CD24, CD3E, SIRPB1, TNFSF13B, DUSP10, CTLA4, CCR7, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, VAV1, ZAP70, IFNG, LCK, IL1B, XCL1, HSPD1, PAK1, HLA-DMB, CCL5, CCL2, FYN, CSK, CCL19, IL12RB1, CCL21, LILRB1, LILRB2, CD4, CD40LG, CD6, DNAJA3, HLA-DPB1, PTPN6]
GO:0071971;extracellular exosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;78.52017720765392;9.777073627680469;0.002627999667568557;0.7902410118609202;[CD34]
GO:0051042;negative regulation of calcium-independent cell-cell adhesion;7.0;1.0;0.8509193652572005;9.628524252492122;69.05345888857988;9.777073627680469;0.002311157124922504;0.8509193652572005;[BMP2]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, BMP2, ID1, ENG]
GO:0060290;transdifferentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;7.9853141584524145;7.050676185779127E-4;0.6583693374183408;[CD34]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[MEF2C, MYOCD, BMP2, NOX4, SIK1]
GO:0031953;negative regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;780.3281191277907;7.379178354882098;0.026116879897493853;0.7926125360964777;[NLRP12, JUN, CAV1, ENG]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, BMP2, LTF]
GO:0060396;growth hormone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[GHR, GH1, PTK2]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, CYR61, LTF, CTHRC1]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL]
GO:2001264;negative regulation of C-C chemokine binding;6.0;1.0;0.8231203125901445;9.628524252492122;47.53015703769362;9.777073627680469;0.0015907915816874183;0.8231203125901445;[CCL23]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[CHRM2, CHRM1, GRIK3, GRM5, RGS1, PRKACB, PTGDR, LHCGR, PTGIR, GPR37, ANXA1, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, PLN, CNR1, NPY, HRH4, PSAP, FLNA, CCL2, S1PR3, DRD4, CCR1, ABCA1, GABBR1, HTR1E, TSHR, MARCO, RAMP1, LGR4]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[JUN, TGFB2, TGFB1, INHBA, FOS, BMP2]
GO:0060317;cardiac epithelial to mesenchymal transition;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;24.75510523691153;6.481236761676141;8.285310941311355E-4;0.6545710619905948;[TGFB2, TMEM100, TGFBR3, BMP2, ENG]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ASGR1, ASGR2, CD36, FCER1G, SYK, DNM2, CEACAM1, COLEC12, LRP1, CD5L, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[BMP2, IL1B]
GO:0072011;glomerular endothelium development;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;41.716971210279375;8.67846133901236;0.0013962294835714489;0.8188169164668168;[PECAM1, CD34]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, JUN, PKIG, EZH2, SIRT1, MMP12, BTAF1, FLNA, LGR4, GMNN, CTGF, FOXO1, NFKB1, CIITA, LRRK2, FASLG, HHEX, PEG3, FYN, E2F7, PRRX1, EIF3E, UXT, MIF, SFRP2, KCNQ1, NAIP, PCBP3, CCR1, EGR1, MSR1, ID1, CD28, CTSZ, PTPRK, CD3E, CD36, CD34, BANK1, IL1B, LOXL2, CCNE1, CALCA, CAV1, HMGA1, BMP2, MXD1, HMGB2, MYOCD, ELF3, FBP1, PHB2, MYB, HOXA2, HOXA7, HOXB4, HOXB3, PRDM16, ELANE, BARD1, NDFIP2, CDKN1A, HAVCR2, PAWR, PAX5, PAX2, AES, GAS1, ENG, NR1H2, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, NACC2, WFS1, LSM5, LSM3, BCL6, CNOT3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, NLRC4, RBBP8, ZNF503, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, MDFIC, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, IFNG, PFDN5, THBS1, MEIS2, RBMX]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, ADCYAP1, NPY, PNOC, PROK2, GPR19]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, S1PR3, TGFB1, JAG1, KRT19, BMP2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, AZU1, COL1A1, HOXC10, FOS, SIRT1, MMP12, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, NFKB1, CXCL10, MYD88, CIITA, HHEX, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, RGMA, IL1B, KIT, YAP1, IL17A, CD86, CD80, ACTG2, CCNE1, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, ACTA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, POLR2E, POLR2K, POLR2L, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:2000726;negative regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;669.6541776470041;7.292166977892469;0.022412722676212672;0.769162383550154;[PAK1, BMP2, DLL1]
GO:0072254;metanephric glomerular mesangial cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;167.73822792981989;9.777073627680469;0.0056140475342067375;0.8509193652572005;[CD34]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[BRCA2, CTGF, RUVBL2, PDGFRB, GHSR, ANXA1, DUSP1, TACR3, IL1B, PCNA, ABCB4, PTGS2, RBBP8, TGFB1, COL1A1, GH1, CD4, EZH2]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;7.0;0.811012628672052;0.7564256795932265;9.318369324188282;71.23621840810117;5.132682728539097;0.0023842121216848507;0.6134049986888465;[TGFB1I1, EMILIN1, MEN1, MYOCD, SIRT1, DNM2, TGFBR3, ENG, THBS1, PRDM16, TGFB1, CAV2, CAV1, LRG1]
GO:0010466;negative regulation of peptidase activity;9.0;0.7090535922965819;0.75076742132858;9.3498108500231;435.8964092118286;4.224114042758852;0.014589060535020671;0.6122620137683685;[PROS1, SPINT2, RPS6KA1, AKT1, POR, SFRP2, SPINT1, SLPI, NAIP, SFN, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, ECM1, SERPINA1, TIMP3, TIMP1, CR1, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, LTF, SERPINB10, NLRC4, PTGS2, THBS1, SPOCK3]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB2, TGFB1, INHBA, BMP2, ENG]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, COL1A1, NOX4, NRP1, NRP2, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, PDGFRA, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB2, TGFB1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, ARHGAP15, CORO1A, SPTA1, MYH14, PTK2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3]
GO:0061036;positive regulation of cartilage development;6.0;0.8259837884571596;0.7361122068187242;9.36615998802463;85.07595514026741;6.375876246018314;0.00284741565515604;0.6491829203200885;[POR, BMP2, RUNX2, CYR61, HOXA11, LOXL2]
GO:2000065;negative regulation of cortisol biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;1464.246860894009;8.390779266560578;0.04900702469750238;0.8615337942327104;[BMP2]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[PTAFR, AQP9, SLC8A1, JUN, DUSP1, FOS, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, TEK, SLC26A3, CFTR]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB2, BMP2, TGFB1, KLF5, PRL, FOS]
GO:0003198;epithelial to mesenchymal transition involved in endocardial cushion formation;7.0;1.0;0.8509193652572005;9.628524252492122;26.141399598032546;7.379178354882098;8.749291188139309E-4;0.728290889492758;[TMEM100, ENG]
GO:1905007;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;8.0;1.0;0.875;9.628524252492122;277.7728422204446;8.16763571524637;0.009296807049790315;0.7926932703116032;[TGFB2, ENG]
GO:0043569;negative regulation of insulin-like growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;7.9853141584524145;0.006272590372058239;0.7592887026755414;[BMP2]
GO:0043568;positive regulation of insulin-like growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;7.212124270218933;0.006257069970731893;0.7197477358342742;[GH1, GHSR, CDH3]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[ECM1, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, IRAK3, MMP12, IL6, PTPRC, PXDN, PADI2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F7, PRRX1, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX4, TWIST1, PCBP3, EGR1, BCL11A, ID1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, IL1B, EZH2, ENG]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, PLXND1, SFRP2, COL4A1, ENG]
GO:0042482;positive regulation of odontogenesis;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;103.86878039186215;7.379178354882098;0.0034763946038822383;0.728290889492758;[BMP2, TGFB1, CD34]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0032100;positive regulation of appetite;9.0;1.0;0.896240625180289;9.628524252492122;112.0314975677904;8.390779266560578;0.003749593401792039;0.8253454670833372;[GHSR, NPY]
GO:0032348;negative regulation of aldosterone biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;1299.8819356928807;8.390779266560578;0.043505878569849596;0.8443458537639685;[BMP2]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MEF2C, CXADR, PRKCQ, HHLA2, FPR1, FPR3, FPR2, GATA3, KLRK1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, HLA-DRB1, DENND1B, ITK, SIGLEC9, CTLA4, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, NFAM1, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, KIR3DL1, HLA-DPB1, PKN1, CLC, LGR4, PROS1, CXCL13, TNF, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, ADCYAP1, CLEC4D, MSH2, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, HLA-DRA, LAT, MYD88, ITGAM, TREM2, PTPN22, TREM1, TNFSF13B, FCGR3A, DUSP10, CR2, CR1, CHUK, PVRIG, LCK, XCL1, LCP2, UNC93B1, NLRC4, CCL5, FYN, CSK, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, LGALS3, ICOSLG, SLC11A1, MIF, BTK, STXBP2, CD1E, CD1D, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, PAG1, SH2D1A, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, FCER1G, SYK, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, PAK1, IGKC, NPDC1, LILRB1, LILRB2, MLH1, CD40LG, CD86, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, OSCAR, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, KIR2DL3, KIR2DL4, STAP1, NLRP3, TGFB2, TGFB1, CAV1, NFKBIA, IL6, NR4A3, KLRD1, IGKV3-20, HMGB2, TNFAIP3, PDE4B, IRAK3, FGR, ZAP70, IFNG, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, TRAT1, MAPK14, CD4]
GO:0071636;positive regulation of transforming growth factor beta production;6.0;0.7980440201809971;0.722142322680643;9.34084218004034;65.64212018022187;6.943860283624253;0.0021969826883592772;0.6782296504172152;[LUM, MYB, XCL1, PTGS2, THBS1, CD34]
GO:0043615;astrocyte cell migration;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;22.237500671838706;7.9853141584524145;7.442691350351552E-4;0.7314896500084853;[CCL2, APCDD1]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SLA2, AKT1, PRKACB, GATA3, DUSP2, DUSP1, DUSP6, IL12RB2, PKN1, EFEMP1, KCNH1, FBXW2, BLK, PKMYT1, NAE1, BMX, HM13, IL2RG, EIF4H, FYN, IL2RB, EIF3F, C1GALT1C1, TNFSF11, SNRPD3, ALG8, BTC, BTK, NAIP, SDC2, EGR2, PTK2, MUC15, SPTAN1, SYK, IL1B, KIT, PCNA, KITLG, NDUFAB1, LOXL2, UBE2M, TNFAIP3, GHR, IRAK3, SPOCK3, TEK, HMBS, PRKCQ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, ASGR1, ASGR2, TIMP1, CIT, GSN, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, MAP2K6, COPS5, P4HA2, CCDC22, LAT, GAL3ST1, CYR61, LCK, TPTE, NLRC4, TTR, CSK, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, PRL, ZDHHC17, HCK, TLR7, TLR4, TLR2, QPCT, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, THBS1, BUB1, WEE1, EHMT2, MYLK, KRTCAP2, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, IQGAP3, LYN, ABCA1, HACE1, LYZ, EZH2, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A8, FOXO1, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, UTY, DSP, PPP1R12A, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, CCNH, EPHB1, PAQR3, ALPK2, EPHA3, EPHA2, PTPRR, FKBP14, PTPRK, BRCA2, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP4, SPTA1, CLK4, CLK1, IL6, BMP2, LAMC1, TAF9, GALNT7, GALNT6, EGF, LAMB1, MAPK14, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, MELK, CUL5, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, PTPN22, DUSP10, CHUK, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, SGK1, RANBP2, CAMK4, GALNT14, ARID4A, ARID4B, FBL, CSF2RB, ADRB2, TGFB2, TGFB1, NFKBIA, TGFBR3, FGR, NCAM1]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[AKT1, MEF2C, F2R, MSH2, NAIP, C5AR1, SLC30A10, CORO1A, JUN, WFS1, NR4A2, NR4A3, NRP1, LRRK2, CHL1, CD34, SIRT1, LRP1, GPNMB, NTF3, CCL2, FYN, GABRA5]
GO:0042487;regulation of odontogenesis of dentin-containing tooth;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;47.77839987207684;7.138016298065211;0.0015991000459501783;0.7159578506919597;[BMP2, RUNX2]
GO:0048468;cell development;3.0;0.5052934683962566;0.45076704678827284;6.510574346213882;28.41553699003407;3.2909128387363804;9.510424507334451E-4;0.36641774820622075;[AKT1, TNFSF11, HOXA2, SOX4, MEF2C, CXADR, RUNX2, SFRP2, ABCB4, GATA3, GJC1, SFN, TSPAN2, NCKAP1L, LYN, JAG1, BCL11B, SDC1, ROBO2, GABRB1, KIT, ENG, TLR2, COL11A1, NPY, FLNA, DMD, JAM3, GSN, GABRA5, MLH1, SULF2, PLP1, FMR1, ARID4A, ARID4B, SLC8A1, CLEC5A, MEN1, MSH2, S100A8, MYH11, EIF2B3, TGFB2, TGFB1, CAV2, INHBA, BMP2, LIN28A, PTPRC, BCL6, UQCRQ, LSR, TGFBR3, ACTA2, PALLD, DLL1, WASF3, SLC4A7, MEIS1, KLF5, CD9, PTPN6]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, EHMT2, SLA2, SPIB, AKT1, MEF2A, MEF2C, ATF3, GATA3, JUN, JAG1, JUP, PKIG, EZH2, HOXC10, FOS, SIRT1, MMP12, MED23, PTAFR, STAT4, ZNF467, USP9Y, ATAD2, PSMC6, PSMC2, PKN1, CCNT2, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, NFKB1, CXCL10, CIITA, FASLG, HHEX, PPP1R12A, PEG3, LRP2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, UXT, TNFSF11, SFRP4, SFRP2, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, PCSK6, CD3D, CD36, RGMA, IL1B, KIT, YAP1, IL17A, NR3C2, LOXL2, CCNE1, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, HMGB2, ARHGEF10L, MYOCD, ELF3, FBP1, CREB5, TAF9, MAPK14, EHF, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, ELANE, NKX2-3, NFE2, FZD5, CDKN1A, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, ENG, EPCAM, NR1H2, GTF2H1, ELP4, PF4, PLXND1, TNF, DACH1, MEN1, TLE4, NACC2, WFS1, HOPX, COPS5, BCL6, MAFF, CYR61, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, RBBP8, KLF1, KLF8, KLF5, DNAJA3, PPIL4, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, PFN1, BEX1, TWIST1, NHLH2, BCL11B, BCL11A, AHCTF1, PRL, XPO1, TLR4, TLR2, LILRB1, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, CKAP2, DCN, TGFBR3, IFNG, DLL1, HSPD1, LUM, MEIS2, MEIS1, RBMX]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ATP1B1, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, CCL21, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, SFRP4, SFRP2, PFDN5, FOXO1, FRZB, CTHRC1, EGR1, CAV1, TMEM64, MAPK14, BMP2]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, RNASE6, RNASE3, CHIT1, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, CD1D, KLRK1, NLRP3, S100A14, IGHA1, ELANE, DEFA4, CAV1, PRG2, AZU1, DEFA1, PPBP, LYZ, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, SERPINB9, TLR1, FGR, IGHD, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, PTAFR, NLRC4, IGKC, CCL2, CCL20, CARD9, CD4, FCGR2B]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL21, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, ATF3, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, LCK, NLRC4, CCL5, CCL2, P2RX1, MNDA, PPP2R1A, SOX4, SFRP4, SFRP2, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, CTSZ, CTSH, VAV1, IL1B, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, PDGFRB, NLRP3, TGFB2, TGFB1, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, MMP9, DNM2, IFNG, BCL2A1, THBS1, HSPD1, CNR1, HSPE1, LTBR]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, UQCRC1, PRKCQ, UQCRC2, ENPEP, GATA3, ADAMTS12, ELANE, BARD1, ST14, ACE, HACE1, AZU1, TGFB1I1, MMP28, OLR1, SIRT1, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, FBXW2, ADAM2, ADAM9, ADAM7, CUL5, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, ADAMTS1, ADAMTS20, HM13, RNF24, EIF3F, ANPEP, SKP2, CFTR, CTSZ, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, C1QA, CD5L, IGKC, RANBP2, RANBP1, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, ADRB2, TRHDE, DPP4, NLRP3, TGFB1, NFKBIA, IGKV3-20, TNFAIP3, MMP8, MMP9, LTF, RBMX]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, ADAMTS12, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, KMO, NFKB1, CHI3L1, XCL1, RBMX, IL17A]
GO:0002828;regulation of type 2 immune response;5.0;0.7866048967936545;0.6835434602577475;9.117698628726131;25.624977988756285;6.375876246018314;8.576449523007288E-4;0.6163036195908642;[CD86, ECM1, ANXA1, ARG1, IFNA2, GATA3, IL6, BCL6, NLRP3, XCL1, CCR2]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:2000502;negative regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1002.759017369874;9.083926447120524;0.03356144188684441;0.8969813732811862;[KLRK1, CCL2]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, HSPD1, PYCARD, CD40LG, CD28, XCL1, TLR4, CD34, TLR2]
